SCHEMBL4186166

SCHEMBL4186166

CC(C)CC1(CO)COC1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.48
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364497 0.91 EPHX1 (0.39) EPHX1
SCHEMBL9619368 0.80 EPHX1 (0.38) EPHX1
SCHEMBL13567325 0.78 EPHX1 (0.33) EPHX1
SCHEMBL13143433 0.77 EPHX1 (0.34) EPHX1
SCHEMBL104600 0.77
SCHEMBL24627154 0.76 EPHX1 (0.32) EPHX1
SCHEMBL521656 0.76
SCHEMBL9191305 0.75
SCHEMBL16077744 0.74 EPHX1 (0.31) EPHX1
SCHEMBL10020999 0.73 TSHR (0.32) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11958971-B2 Photocurable composition, method for producing concave-convex structure, method for forming fine concave-convex pattern, and concave-convex structure MITSUI CHEMICALS, INC. (JP) 2024-04-16 US disclosed
CN-110741463-B Method for producing substrate with fine concave-convex pattern, resin composition, and laminate 三井化学株式会社 2024-02-20 CN disclosed
CN-113574086-B Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure 三井化学株式会社 2023-11-07 CN disclosed
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION PFIZER INC. 2023-08-31 US disclosed
US-20230183222-A1 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives GRUENENTHAL GMBH (DE) 2023-06-15 US disclosed
US-11597910-B2 Medical instrument, cell culture method, fluorine-containing cyclic olefin polymer and fluorine-containing cyclic olefin polymer composition for it, and cultured cells MITSUI CHEMICALS, INC. (JP) 2023-03-07 US disclosed
US-11474429-B2 Method of producing substrate with fine uneven pattern, resin composition, and laminate MITSUI CHEMICALS, INC. (JP) 2022-10-18 US disclosed
EP-3998298-A1 PHOTOCURABLE COMPOSITION, PRODUCTION METHOD FOR UNEVEN STRUCTURAL BODY, METHOD FOR FORMING MINUTE UNEVEN PATTERN, AND UNEVEN STRUCTURAL BODY Mitsui Chemicals, Inc. (JP) 2022-05-18 EP disclosed
US-20220135787-A1 PHOTOCURABLE COMPOSITION, METHOD FOR PRODUCING CONCAVE-CONVEX STRUCTURE, METHOD FOR FORMING FINE CONCAVE-CONVEX PATTERN, AND CONCAVE-CONVEX STRUCTURE MITSUI CHEMICALS, INC. (JP) 2022-05-05 US disclosed
CN-113574086-A Photocurable composition, method for producing uneven structure, method for forming fine uneven pattern, and uneven structure 三井化学株式会社 2021-10-29 CN disclosed
US-8637557-B2 Aminothiazole derivative TAISHO PHARMACEUTICAL CO., LTD (JP) 2014-01-28 US disclosed
US-20140021648-A1 IMPRINT PRODUCT AND METHOD FOR PRODUCING THE SAME MITSUI CHEMICALS, INC. (JP) 2014-01-23 US disclosed
US-20130172317-A1 TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION HAVING AN ANALGESIC ACTIVITY COMPRISING THE SAME SHIONOGI & CO., LTD. (JP) 2013-07-04 US disclosed
US-20120220767-A1 AMINOTHIAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2012-08-30 US disclosed
US-20120156448-A1 FLUORINE-CONTAINING CYCLIC OLEFIN POLYMER COMPOSITION, IMPRINT PRODUCT OBTAINED USING THE COMPOSITION, AND METHOD FOR PRODUCING THE SAME MITSUI CHEMICALS INC (JP) 2012-06-21 US disclosed
US-20110301313-A1 IMPRINT PRODUCT AND METHOD FOR PRODUCING THE SAME MITSUI CHEMICALS, INC. (JP) 2011-12-08 US disclosed
US-7612123-B2 Cyclohexene oxide compound having cyclohexyl group or long-chain alkyl group, and use thereof TOAGOSEI CO., LTD. (JP) 2009-11-03 US disclosed
EP-1798251-B1 CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR BRANCHED LONG-CHAIN ALKYL GROUP AND USE THEREOF TOAGOSEI CO LTD (JP) 2009-02-25 EP disclosed
US-20080108725-A1 Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof TOAGOSEI CO., LTD. (JP) 2008-05-08 US disclosed
EP-1798251-A1 CYCLOHEXENE OXIDE COMPOUND HAVING CYCLOHEXYL GROUP OR LONG-CHAIN ALKYL GROUP AND USE THEREOF TOAGOSEI CO., LTD. (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120220767-A1 AMINOTHIAZOLE DERIVATIVE AKT3, AKT2, JAK1 EPHX1 4796/4885TSHR 1612/4885
US-20080108725-A1 Cyclohexene Oxide Compound Having Cyclohexyl Group or Long-Chain Alkyl Group, and Use Thereof RAD51, HEATR1, DCXR EPHX1 492/4885TSHR 3435/4885
US-20230270751-A1 BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION CNR1, CNR2, SIGMAR1 EPHX1 2427/4885TSHR 80/4885
US-20230183222-A1 8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives OPRK1, OPRD1, OPRL1 EPHX1 2434/4885TSHR 2683/4885
US-20130172317-A1 TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION HAVING AN ANALGESIC ACTIVITY COMPRISING THE SAME P2RX3, P2RX4, P2RX2 EPHX1 913/4885TSHR 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.